SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-119452
Filing Date
2016-08-15
Accepted
2016-08-15 16:18:59
Documents
38
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v446627_10q.htm 10-Q 260750
2 EXHIBIT 10.1 v446627_ex10-1.htm EX-10.1 54953
3 EXHIBIT 31.1 v446627_ex31-1.htm EX-31.1 10553
4 EXHIBIT 31.2 v446627_ex31-2.htm EX-31.2 10729
5 EXHIBIT 32.1 v446627_ex32-1.htm EX-32.1 4319
6 EXHIBIT 32.2 v446627_ex32-2.htm EX-32.2 4255
  Complete submission text file 0001144204-16-119452.txt   1897673

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT accp-20160630.xml EX-101.INS 292746
8 XBRL TAXONOMY EXTENSION SCHEMA accp-20160630.xsd EX-101.SCH 18676
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE accp-20160630_cal.xml EX-101.CAL 37349
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE accp-20160630_def.xml EX-101.DEF 96884
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE accp-20160630_lab.xml EX-101.LAB 258575
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE accp-20160630_pre.xml EX-101.PRE 156298
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 161832984
SIC: 2834 Pharmaceutical Preparations